Status epilepticus (SE) is an acute, life-threatening medical condition that requires
immediate, effective therapy. Therefore, the acute care of prolonged seizures and SE is a …

Status epilepticus (SE) treatment strategies vary substantially from one institution to another
due to the lack of data to support one treatment over another. To provide guidance for the …

Background Refractory status epilepticus (RSE) is a life-threatening condition in which
seizures do not respond to first-and second-line anticonvulsant drug therapy. How often …

Propofol (2, 6-diisopropylphenol) is a potent intravenous hypnotic agent which is widely
used for the induction and maintenance of anesthesia and for sedation in the intensive care …

The objective of the current article was to review the literature and discuss the degree of
evidence for various treatment strategies for status epilepticus (SE) in adults. We searched …

Background: New continuous infusion antiepileptic drugs (cIV‐AEDs) offer alternatives to
pentobarbital for the treatment of refractory status epilepticus (RSE). However, no …

Summary As in Clark and Prout's classic work, we identify three phases of generalised
convulsive status epilepticus, which we call impending, established, and subtle. We review …

Objective: To assess risk factors and prognosis in patients with refractory status epilepticus
(RSE). Methods: We retrospectively analysed all episodes of status epilepticus (SE) treated …

Purpose: Established tonic–clonic status epilepticus (SE) does not stop in one-third of
patients when treated with an intravenous (IV) benzodiazepine bolus followed by a loading …

Objective To further characterize the demographics, outcomes, and prognostic factors for
refractory status epilepticus (RSE). Design Retrospective analysis of all the episodes of RSE …